{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:42:21Z","timestamp":1787964141982,"version":"build-2784847793"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.contraception.2022.07.009","type":"journal-article","created":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T09:58:52Z","timestamp":1659261532000},"page":"37-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Pooled efficacy results of estetrol\/drospirenone combined oral contraception phase 3 trials"],"prefix":"10.1016","volume":"116","author":[{"given":"Jeffrey T.","family":"Jensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Kaunitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.","family":"Achilles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1nos","family":"Zatik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Weyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terhi","family":"Piltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Suturina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna","family":"Apolikhina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Bouchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Apter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Jost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean\u2013Michel","family":"Foidart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell D.","family":"Creinin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2022.07.009_bib0001","first-page":"207","article-title":"Metabolism of 17\u2013Beta\u2013Oestradiol\u20134\u201314\u2013C in early infancy","volume":"49","author":"Hagen","year":"1965","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.contraception.2022.07.009_bib0002","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.15252\/emmm.201404112","article-title":"The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor alpha modulation, uncoupling nuclear and membrane activation","volume":"6","author":"Abot","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.contraception.2022.07.009_bib0003","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1152\/physrev.00024.2016","article-title":"Membrane and nuclear estrogen receptor alpha actions: from tissue specificity to medical implications","volume":"97","author":"Arnal","year":"2017","journal-title":"Physiol Rev"},{"key":"10.1016\/j.contraception.2022.07.009_bib0004","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.contraception.2020.08.015","article-title":"Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters","volume":"102","author":"Douxfils","year":"2020","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2022.07.009_bib0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1530\/JOE-14-0549","article-title":"Estetrol is a weak estrogen antagonizing estradiol\u2013dependent mammary gland proliferation","volume":"224","author":"Gerard","year":"2015","journal-title":"J Endocrinol"},{"key":"10.1016\/j.contraception.2022.07.009_bib0006","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.contraception.2016.08.018","article-title":"Reduced hemostatic effects with drospirenone\u2013based oral contraceptives containing estetrol vs. ethinyl estradiol","volume":"95","author":"Kluft","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2022.07.009_bib0007","first-page":"463","article-title":"Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives","volume":"20","author":"Mawet","year":"2015","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2022.07.009_bib0008","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.contraception.2021.03.003","article-title":"Effects of an oral contraceptive containing estetrol and drospirenone on ovarian function","volume":"103","author":"Duijkers","year":"2021","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2022.07.009_bib0009","first-page":"476","article-title":"Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose\u2013finding pilot study","volume":"20","author":"Duijkers","year":"2015","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2022.07.009_bib0010","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.contraception.2016.04.015","article-title":"Bleeding pattern and cycle control with estetrol\u2013containing combined oral contraceptives: results from a phase II, randomised, dose\u2013finding study (FIESTA)","volume":"94","author":"Apter","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2022.07.009_bib0011","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.contraception.2009.04.011","article-title":"Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic\u2013pituitary\u2013ovarian activity","volume":"80","author":"Edelman","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2022.07.009_bib0012","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.contraception.2021.01.001","article-title":"Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone","volume":"103","author":"Klipping","year":"2021","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2022.07.009_bib0013","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.contraception.2021.05.002","article-title":"Estetrol\u2013drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results","volume":"104","author":"Creinin","year":"2021","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.contraception.2022.07.009_bib0014","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/1471-0528.16840","article-title":"Estetrol\u2013Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia","volume":"129","author":"Gemzell\u2013Danielsson","year":"2022","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2022.07.009_bib0015","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.contraception.2014.03.018","article-title":"Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population","volume":"90","author":"Gerlinger","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2022.07.009_bib0016","doi-asserted-by":"crossref","first-page":"e1054","DOI":"10.1016\/S2214-109X(19)30265-7","article-title":"Efficacy of the 1\u2013year (13\u2013cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open\u2013label, single\u2013arm, phase 3 trials","volume":"7","author":"Archer","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.contraception.2022.07.009_bib0017","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/13625187.2016.1241991","article-title":"Fertility and combined oral contraceptives \u2013 unintended pregnancies and planned pregnancies following oral contraceptive use \u2013 results from the INAS\u2013SCORE study","volume":"22","author":"Barnett","year":"2017","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2022.07.009_bib0018","first-page":"1","article-title":"Wake up and smell the condoms: an analysis of sex education programs in the United States, the Netherlands, Sweden, Australia, France, and Germany","volume":"2009","author":"Bell","year":"2022","journal-title":"Inquiries Journal\/Student Pulse"},{"key":"10.1016\/j.contraception.2022.07.009_bib0019","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.contraception.2013.04.001","article-title":"The creeping Pearl: why has the rate of contraceptive failure increased in clinical trials of combined hormonal contraceptive pills?","volume":"88","author":"Trussell","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2022.07.009_bib0020","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/aje\/kwm221","article-title":"Obesity and oral contraceptive failure: findings from the 2002 National Survey of Family Growth","volume":"166","author":"Brunner Huber","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.contraception.2022.07.009_bib0021","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.contraception.2010.01.016","article-title":"Pharmacokinetics of a combined oral contraceptive in obese and normal\u2013weight women","volume":"81","author":"Westhoff","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2022.07.009_bib0022","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1503\/cmaj.121280","article-title":"Contraception in women over 40 years of age","volume":"185","author":"Allen","year":"2013","journal-title":"CMAJ"},{"key":"10.1016\/j.contraception.2022.07.009_bib0023","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1124\/dmd.105.003822","article-title":"CYP3A5 genetic polymorphisms in different ethnic populations","volume":"33","author":"Roy","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.contraception.2022.07.009_bib0024","doi-asserted-by":"crossref","first-page":"E646","DOI":"10.9778\/cmajo.20190087","article-title":"Household income and contraceptive methods among female youth: a cross\u2013sectional study using the Canadian Community Health Survey (2009\u20132010 and 2013\u20132014)","volume":"7","author":"Nethery","year":"2019","journal-title":"CMAJ Open"},{"key":"10.1016\/j.contraception.2022.07.009_bib0025","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/AOG.0000000000003189","article-title":"Influence of genetic variants on steady\u2013state etonogestrel concentrations among contraceptive implant users","volume":"133","author":"Lazorwitz","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2022.07.009_bib0026","article-title":"On racism: a new standard for publishing on racial health inequities","author":"Boyd","year":"2020","journal-title":"Health Aff Blogs"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782422002153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782422002153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:22:19Z","timestamp":1757881339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782422002153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":26,"alternative-id":["S0010782422002153"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2022.07.009","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pooled efficacy results of estetrol\/drospirenone combined oral contraception phase 3 trials","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2022.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}